London-based drugmaker GSK has announced the UK approval of Nucala (mepolizumab) as an add-on maintenance biologic treatment ...

Wegovy (semaglutide) pill is now available, providing those seeking help with their weight the revolutionary science of GLP-1 ...

Chinese RNA drug developer Ribo has launched a Hong Kong IPO, positioning its lead siRNA candidate for thrombotic diseases as ...

Shares of US immunology focused biotech Zenas BioPharma tumbled more than 50% to $17.08 pre-market today despite announcing ...

New York-based clinical-stage cancer and rare diseases drug developer Protara Therapeutics today announced that the US Food ...

China-based Insilico Medicine, an AI-driven drug discovery firm, announced a multi-year research and development (R&D) ...

Paul Burden (pictured, above) has been appointed associate vice president and country head of Accord UK, effective ...

Suzhou-based Otovia Therapeutics has raised close to 100 million yuan ($14 million) in a new financing round, with support ...

Taiwanese drugmaker ScinoPharm (TWSE: 1789) has secured approval from the US Food and Drug Administration for its glatiramer ...

The sales of the anti-cancer agent Jevtana IV Infusion 60 mg (cabazitaxel) will be transferred from French pharma major ...

French pharma Sanofi (Euronext: SAN) has won US priority review for Tzield (teplizumab-mzwv), aiming to extend use to ...

Abingworth, a transatlantic life sciences investment firm and part of global investment firm Carlyle, today announced several ...